Trading Companies and Distributors

STARCOIN GROUP

Marvel Nice Plans to Acquire StarTaichain's RMB 715 Million Convertible Bonds

Star Galaxy Chain Group Signs Five-Year Research Agreement with Johns Hopkins Extension Lab

STARCOIN GROUP released FY2026 Q1 earnings on November 28, 2025 (BJT), with actual revenue of HKD 1.603 M and EPS of HKD -0.0298

STARCOIN GROUP released FY2026 Q2 earnings on November 28 During-Market (BJT), actual revenue HKD 1.603 M, actual EPS HKD -0.0298

STARCOIN GROUP released FY2026 Semi-Annual Earnings on November 28 During-Market BJT, actual revenue HKD 3.206 M, actual EPS HKD -0.0597

STARCOIN GROUP FY2026 Q2 Earnings Release Scheduled for November 28, 2025 During-Market BJT

Starcoin Token Launches Token-Stock Integration Project on Conflux eSpace Blockchain

Concord Pharmaceutical Biotechnology issues 148.5 million convertible shares

Wu Ming Appointed as CEO of Linghang Pharmaceutical Biotechnology

Leading Pharmaceutical Biotechnology Shares Suspended from Trading

Navigate Biopharma Raises Capital Through Share Issuance

Lighthouse Pharmaceutical Biotechnology Terminates Subscription Agreement

Concord Pharmaceutical Biotechnology issued 149 million convertible shares

Leading Pharmaceutical Biotech intends to Acquire Conflux to Enter Blockchain Field

Innovative Pharmaceutical Biotech Suggests Name Change and Capital Increase

Navigate Pharmaceutical Biotech Inc. Posts Larger Loss in 2025 Fiscal Year

Navigate Biopharma Seeks to Acquire Blockchain Tech Firm

INNOVATIVE PHAR released FY2025 Q3 earnings on June 30 (BJT), actual revenue HKD -469K, actual EPS HKD -0.1298

Innovative Phar released FY2025 9 Months Earnings on June 30 BJT with actual revenue of HKD 2.56 M and EPS of HKD -0.1318

Innovative Phar released FY2025 Annual Earnings on June 30 Pre-Market (BJT), actual revenue HKD 2.091 M, actual EPS HKD -0.2001

HINSANG GROUP

RIVERINE CHINA

PASHUN INT RTS

BRAINAURORA-B

SOFTMEDX

GOLDENPOWER

ZHONGKE GROUP

VISION SYNERGY

GEMILANG INTL

GHPC

00388

00399

Starcoin Group Limited's trading suspension by the Hong Kong Stock Exchange has been upheld due to insufficient operations and assets. The company has secured an interim injunction to block the suspension and plans to seek judicial review. This situation raises concerns for shareholders and highlights increased regulatory scrutiny of underperforming companies in Hong Kong. Trading remains active as the legal process unfolds, with the company's market cap at HK$361.1M and a strong sell sentiment in the market.

Tip Ranks

HKEX

Starcoin Secures Injunction as HKEX Panel Upholds Trading Suspension Decision

00842

08661

09963

Hong Kong stock market overview in the past hour Market sentiment seems to be gradually warming up amid recent fluctuations, especially with active performances in the technology and new energy sectors. The strong rise of LEOCH INT'L has attracted capital, driving the overall increase in related sectors. Meanwhile, the significant decline of JIAODA WITHUB indicates a divergence in market strength, with short-term capital preferences seemingly switching continuously. Overall, short-term enthusiasm has increased, volatility has intensified, and investor sentiment is relatively active. The most notable stock movement in the past hour LEOCH INT'L surged 67.86%, becoming the market focus. The stock quickly rose in the morning session, attracting a large influx of capital, with short-term sentiment high, seemingly indicating optimistic expectations for its future development. Strong stocks 1. INTELLIMARK W27: up 45.83%, recent market attention on its technological innovations has increased, with significant capital inflow. 2. TRANSTECH: up 29.08%, benefiting from the recovery in industry prosperity, with short-term capital actively involved. 3. METASPACEX: up 27.04%, the market is full of expectations for its digital transformation prospects, driving the stock price up. 4. SHANDONG MOLONG: up 21.79%, market sentiment is warming amid rising resource prices. 5. RUICHANG INTL: up 19.25%, the activity of short-term capital has led to a continuous rise in its stock price. 6. EXTREME VISION: up 17.77%, benefiting from industry trends, with accelerated capital inflow. 7. PETRO-KING: up 16.67%, the market is optimistic about its performance expectations, driving the stock price up

HK Stock Alerts

LEOCH INT'L

INTELLIMARK W27

TRANSTECH

METASPACEX

JIAODA WITHUB

SHANDONG MOLONG

RUICHANG INTL

EXTREME VISION

CH TIANBAO GP

PETRO-KING

TIAN TU CAPITAL

KNOWLEDGE ATLAS

XunZhong

HAIZHI TECH GP

PUXING ENERGY

CHINA FORTUNE

MINIMAX-W

Hong Kong Stock Market Movement Update: LEOCH INT'L surged 67.86%, INTELLIMARK W27 rose sharply, JIAODA WITHUB plummeted 23.26%

08368

02609

The market overview of Hong Kong stocks in the past hour shows significant fluctuations in market sentiment, with a clear divergence in capital flows. Technology and pharmaceutical stocks have become hotspots for capital chasing, especially the strong rise of STARCOIN GROUP, which has attracted a lot of short-term capital attention. Meanwhile, some individual stocks like CREATIVE CHINA have encountered sharp declines, indicating a strong differentiation in the market. Overall, short-term enthusiasm is high, with increased volatility, and investor sentiment seems to be continuously adjusting. 

In the past hour, the stock with the most significant movement is STARCOIN GROUP, which performed impressively, with an increase of 24.76%, repeatedly hitting the upper limit during the session, showing strong buying sentiment. The rapid inflow of funds has attracted numerous investors' attention to this stock in a short period, boosting the activity of related sectors. 

Strong stocks:
1. BAYZED HEALTH: up 16.75%, with recent market attention on its product line, short-term capital actively intervening.
2. JINXUN RESOURCE: up 15.78%, benefiting from rising resource prices, with market sentiment high and noticeable capital inflow.
3. MINIMAX-W: up 15.33%, with active short-term trading attracting participation from speculative funds.
4. INSILICO: up 12.05%, with a strengthening technical outlook and optimistic market sentiment regarding its future development prospects.
5. EPIWORLD: up 11.52%, with the company's recent earnings forecast sparking market discussions and rapid capital follow-up.
6. REMEGEN: up 11.17%, with the overall biotechnology sector strengthening, driving this stock's rise

CREATIVE CHINA

BAYZED HEALTH

JINXUN RESOURCE

INSILICO

EPIWORLD

REMEGEN

DONGFANG ELEC

ILUVATAR COREX

Hong Kong Stock Movement Update: STARCOIN GROUP surges 24.76%, CREATIVE CHINA plummets 26.32%

588860

516930

STARCOIN GROUP signed a memorandum of understanding with Huamei Haibo to explore cooperation in biotechnology and the digital economy. Both parties will leverage resource sharing and complementary advantages to identify potential collaboration opportunities, including equity investment, asset restructuring, and Web3.0 health chains. Huamei Haibo focuses on the research and development of AI-driven cell manufacturing equipment, while STARCOIN GROUP will utilize its technological advantages to accelerate the integration of Web3.0 and cell technology, enhance competitiveness, and promote the intelligent development of the health industry

AASTOCKS

ICBCCS SSE STAR Biology and Medicine ETF

Minsheng Royal CSI Biotechnology Theme ETF

Huaan Hang Seng Biotech ETF

ChinaAMC CSI Biotechnology Theme ETF

China Southern Hang Seng Biotech ETF(QDII)

China Universal NASDAQ Biotechnology Technology ETF(QDII)

E Fund CSI Biotechnology Theme ETF

Tianhong CNI BIOMEDICINE ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Penghua SSE STAR Biology and Medicine ETF

Guotai CSI Bio-medicine ETF

First Trust NYSE Arca Biotech Index Fd

China Merchants CSI Biotechnology Theme ETF

STARCOIN and Huamei Haibo signed a memorandum of understanding to explore cooperation in the integration of biotechnology and the digital economy

STARCOIN GROUP announced that Marvel Nice intends to acquire its issued convertible bonds worth 715 million yuan. If the acquisition is completed, Marvel Nice will become the bondholder and will subscribe for shares at a price not lower than 1 yuan. This move will help STARCOIN GROUP reduce its liabilities and improve its financial condition, while the introduction of new shareholders may bring future business development opportunities

STARCOIN GROUP: Marvel Nice plans to acquire convertible bonds worth 715 million yuan

Starcoin Group Limited has signed a memorandum of understanding with Marvel Nice Limited for a potential debt-equity deal involving HK$715 million in convertible bonds. Marvel Nice would subscribe for new shares at a minimum of HK$1 per share, offsetting the bonds' principal and interest. This transaction aims to reduce Starcoin's liabilities, attract a strategic investor, and enhance its financial position for its beauty products and oral insulin businesses. The deal is expected to broaden the company's shareholder base and support future growth opportunities.

Starcoin Group Plans Debt-Equity Deal to Cut Liabilities and Add Strategic Investor

GBTC

CORZ

NBRGU

Starcoin Group Limited has signed a memorandum of understanding with Newbridge Acquisition Limited and Conflux Foundation to explore a potential de-SPAC transaction. This deal aims to provide Starcoin access to U.S. capital markets and integrate Conflux’s blockchain technology, enhancing operational reliability and shareholder value. The company, formerly known as Innovative Pharmaceutical Biotech, focuses on blockchain infrastructure and digital asset technologies. The latest analyst rating for its stock (HK:0399) is a Sell with a price target of HK$0.18.

- Innovative Pharmaceutical Biotech has provided an update regarding Starcoin Group Limited's new memorandum of understanding with Newbridge Acquisition Limited and Conflux Foundation, aimed at exploring a potential de-SPAC transaction.  
- This deal intends to facilitate Starcoin's access to U.S. capital markets and enhance its blockchain initiatives, potentially increasing value for shareholders if completed.  
- The current analyst rating for Innovative Pharmaceutical Biotech stock is a Sell, with a price target of HK$0.18.

Grayscale Bitcoin Trust BTC - ETF

Core Scientific, Inc.

Galaxy Digital

Coinbase

Riot Platforms

Grayscale Litecoin Trust (LTC)

Bitfarms Canada

Newbridge Acquisition - Unit

Hut 8 Mining

Bitdeer Tech

Bakkt

Block

Confluent

Mara

Franklin Exponential Data ETF

VanEck Bitcoin ETF

Global X Cloud Computing ETF

ProShares Bitcoin Strategy ETF

First Trust Indxx Innov

Siren ETF Trust Siren Nasdaq NexGen Economy ETF

WisdomTree Bitcoin Fund

Proshares Big Data Refiners ETF

Franklin Bitcoin ETF

Fidelity Wise Origin Bitcoin Fund - ETF

Bitwise Solana Staking ETF

ARK 21Shares Bitcoin ETF

Global X Data Center & Dgtl Infrs ETF

Grayscale Solana Staking ETF

Bitwise Bitcoin ETF

SPDR S&P Software

ISHRS S&P Glb It

Invesco Galaxy Bitcoin ETF

Keel Infrastructure

Starcoin Expands De-SPAC Talks With Newbridge and Conflux to Bolster Blockchain Push

STARCOIN GROUP fell 10.38%; Asia Pacific Resources rose 2.79%, with a transaction volume of HKD 49.71 million; Bank of China Aviation Leasing fell 3.21%, with a transaction volume of HKD 43.48 million; COSCO Shipping Development had a transaction volume of HKD 42.72 million; JD Industrial fell 4.04%, with a market value of HKD 30.7 billion

Hong Kong stock movement: STARCOIN GROUP fell 10.38%, acquisition memorandum of understanding triggered market uncertainty and volatility

STARCOIN GROUP(00399.HK)